Simcone

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Simcone

Property Description
Active Ingredient Simethicone (Activated Dimethicone)
Pharmacological Class Antiflatulent Agent (Surface-Active Agent)
Origin Synthetic (Silicone-based polymer)
Route of Administration Oral
Common Use Relief of gas-related discomfort (bloating, fullness)

What Type of Medicine is Simcone?

Simcone is the trade name for a specific pharmaceutical preparation whose primary active ingredient is Simethicone, which is strictly classified as a non-systemic drug designed to address excess gas in the digestive tract. It belongs to the pharmacological class of antiflatulent agents, distinguished by its action as a surface-active agent. This classification emphasizes that its effect is localized and physical within the gastrointestinal lumen, as the compound is not absorbed into the bloodstream. Because it is not absorbed by the body, it acts only where the gas is present. Simcone is recognized for providing relief from physical symptoms of abdominal distension and bloating associated with trapped gas.


Simethicone: Composition, Origin, and Available Forms

The core compound, Simethicone (activated dimethicone), is a synthetic silicone-based polymer, specifically a blend of polydimethylsiloxane and silicon dioxide. This compound is administered via the oral route in several dosage forms, including oral suspension, chewable tablet, and capsule. As a branded product, Simcone may be specifically known for its liquid oral suspension form, which is often used in pediatric populations. The active ingredient is characterized by its chemical stability and inert nature. The consistency in the active ingredient ensures that, regardless of the form taken, the goal is the localized effect on trapped gas.


How Does Simcone Provide Gas Relief?

Simcone provides gas relief through a defoaming action that operates via a physical mechanism, causing trapped gas bubbles to dissipate. This action occurs because the active ingredient Simethicone acts as a surfactant, lowering the surface tension of the small, foamy gas bubbles within the stomach and intestines. When this tension is reduced, the multiple small bubbles coalesce into fewer, larger bubbles, which are then easier for the body to manage and expel through natural physiological means, such as eructation or flatulence. A typical use scenario involves taking the medicine when a patient experiences acute, gas-related fullness. The general purpose of the medicine is therefore related to mitigating the physical symptoms of pressure caused by gas buildup, providing localized symptomatic relief.

Regulatory References

  1. Simethicone - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Simcone?

Possible Side Effects and Safety Information

Simcone (Simethicone) is classified as a non-systemic drug, meaning the active ingredient is not absorbed into the bloodstream. This property is reflected in its official safety profile, which is generally limited to local reactions.


Officially Documented Adverse Reactions

Regulatory documents primarily list adverse reactions within two System-Organ Classes (SOCs): Gastrointestinal Disorders and Immune System/Skin Disorders. Reactions are mostly classified as uncommon or rare.

System-Organ Class (SOC) Documented Adverse Reaction Listing Frequency Classification
Gastrointestinal Disorders Nausea, Constipation, Loose stools/Diarrhea Uncommon
Immune System / Skin Disorders Hypersensitivity Reactions (e.g., rash, pruritus) Rare

Serious Adverse Reactions and Safety Constraints

The most clinically significant adverse events documented are linked to severe hypersensitivity or allergic reactions. Signs of a severe allergic reaction include swelling of the face, tongue, or throat, hives, and difficulty breathing. These are classified as rare but require immediate attention.

  • Contraindication: Simcone should not be used in individuals with a known hypersensitivity (allergy) to Simethicone or any of the formulation's inactive ingredients.

Population-Specific Safety Notes

Due to the lack of systemic absorption, official regulatory labeling states that Simethicone is not anticipated to have adverse effects during pregnancy or lactation. Furthermore, certain formulations containing phenylalanine require a precautionary note for individuals with Phenylketonuria (PKU).

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Simethicone (Simcone) is defined by the medicine’s non-systemic and physiologically inert classification. As a non-absorbed compound, Simethicone does not enter the bloodstream, which is consistent with the finding in government regulatory labeling that no specific systemic toxic effects are known or documented. Furthermore, official sources state that no cases of severe or life-threatening overdose have been reported in connection with this medicine.

Despite the non-systemic nature and absence of documented symptoms, regulatory agencies provide explicit instructions for seeking emergency care. The mandatory action is to "get medical help or contact a Poison Control Center right away" if an overdose is suspected. This immediate action is deemed critical even if you do not notice any sign or symptoms, emphasizing that professional assessment is required regardless of the absence of clinical signs.

Simethicone is managed with supportive treatment only, and official regulatory documents confirm that no specific antidote is known to exist. There are no population-specific considerations (e.g., pediatric or elderly) documented for increased overdose severity.

Connection to the overall overdose profile

The regulatory documents define the overdose profile for Simcone through its inert status, stating that no systemic toxic effects are anticipated or documented. This physiological constraint is balanced by the explicit requirement that users must seek urgent medical help immediately upon suspected overdose, a mandatory action that governs when emergency attention must be sought.

Therapeutic Uses of Simcone

What Simcone Treats: Main Uses and Benefits

Simcone is indicated for the management of symptoms associated with excessive gas accumulation within the digestive system. This therapeutic application is focused on relieving uncomfortable sensations such as bloating, pressure, fullness, and flatulence.

The medication is commonly utilized to help manage gas buildup in various clinical scenarios. This may include symptomatic use for functional gastrointestinal disorders, as well as being indicated prior to certain diagnostic procedures, such as abdominal ultrasound or endoscopy, where reducing internal gas is helpful for optimal viewing conditions. The active ingredient addresses the gas bubbles, which contributes to the essential benefit of symptomatic relief from gas-related distress.

Simcone's indications typically encompass gas and related discomfort associated with common conditions, including dyspepsia, postoperative gas retention, and irritable bowel syndrome (IBS).


Quick Fact: Relief for Bloating and Pressure


Eligibility and Restrictions for Use

Who Can and Cannot Use Simcone (Simeticone)

This eligibility profile is based strictly on information found in official government regulatory documents.

Simcone is an antiflatulent agent generally considered safe for wide use because it is not absorbed systemically into the bloodstream and works only within the gut.

Regulatory Contraindications

The only absolute exclusion is a known hypersensitivity or allergy to Simcone (Simeticone) or to any of the product's non-active excipients. Use is also cautioned or restricted in cases of known or suspected intestinal obstruction or perforation.

Eligibility Across Special Populations

Population Category Eligibility Status (Official Labeling)
Age Groups Established for all ages: infants, children, and adults.
Pregnancy Safe for use. Not absorbed systemically, so it does not affect the fetus.
Breastfeeding Safe for use. Not absorbed systemically, so it does not pass into breast milk.
Organ Impairment No restrictions based on severe hepatic (liver) or renal (kidney) impairment, as the medicine is not metabolized or excreted systemically.

The drug's non-systemic nature results in a highly permissive eligibility profile compared to systemically acting medicines.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Simcone (Simethicone) is shaped by its action as a physical, non-systemic agent that is not absorbed into the body. This classification means the medicine is not documented to cause systemic pharmacokinetic or pharmacodynamic drug interactions, ruling out interactions involving CYP enzymes or drug transporters in official labels.

Interacting Substance Category Regulatory Outcome
Thyroid Hormones (Levothyroxine) Co-administration may decrease the oral bioavailability and reduce the systemic exposure of the thyroid hormone.
Carbamazepine Associated with reports of elevated serum concentrations and a potential risk of toxicity when co-administered.

Interaction-Related Restrictions and Constraints

Due to the risk of Physical Absorption Interference with sensitive oral medicines, regulatory documents establish mandatory restrictions for specific combinations. The administration of Simcone and Levothyroxine must be separated by a period of at least four hours to minimize the potential for reduced absorption of the thyroid hormone. No medicinal products are formally listed as contraindicated for co-administration with single-ingredient Simcone in government labeling. Official documents provide no explicit documentation of exposure-altering interactions with food, alcohol, or herbal products. Furthermore, there are no specific population-dependent interaction considerations documented for Simcone alone concerning hepatic or renal impairment.

Mechanism of Action

Physical Action on Surface Tension

Simcone is an inert substance that functions as a physical antifoaming agent, acting exclusively within the gastrointestinal lumen. Its primary biological target is the surface tension of liquid contents in the stomach and intestines. This interaction is non-systemic, meaning it is not absorbed into the bloodstream, and it does not engage biological receptors, enzymes, or intracellular pathways. Instead, Simcone physically reduces the chemical forces that stabilize the gas-liquid interface, a step leading to the de-foaming of the GI contents.


Facilitating Gas Coalescence and Elimination

The reduction in surface tension initiates a mechanistic cascade where numerous small, foam-like gas bubbles coalesce (combine) into larger, more voluminous pockets of gas. This physiological change reduces the viscosity of the gut contents, making the gas physically available for propulsion. The substance thus facilitates the body's natural processes of peristalsis and expulsion, contributing directly to the clearance of gas through the upper and lower digestive tract.

Dosage and Administration Information

Simcone is for oral administration across various labeled forms, including capsules, chewable tablets, and liquid suspensions. Usage is typically defined by dosing, frequency, and preparation steps intended to ensure the active ingredient is dispersed correctly within the gastrointestinal tract.

Administration and Dosage Principles

The pattern of use is primarily as-needed (PRN) for symptomatic management. Doses are commonly administered after meals and at bedtime for timing relative to gas accumulation.

Population Single Dose Range Maximum Daily Dosage Limit
Adults (and Children ge 12 yrs) 40 mg to 250 mg 500 mg (not to exceed 4 doses/day)
Children (2–12 yrs) 40 mg 480 mg (not to exceed 12 doses/day)
Infants (Under 2 yrs) 20 mg 240 mg (not to exceed 12 doses/day)

Preparation and Intake Requirements

Specific instructions are provided based on the dosage form. The oral suspension requires the container to be shaken well before use, and the dose is measured using a dosing device. Chewable tablets are chewed thoroughly before being swallowed. Conversely, liquid-filled capsules are swallowed whole and are not to be chewed. Due to its non-systemic nature, the drug's labeled instructions generally do not stipulate dose adjustments for older adults or individuals with renal or hepatic impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Simcone

The clinical evidence for Simcone focuses on research exploring its use for two main areas: studying general discomfort caused by trapped gas, and research exploring its use in preparing the digestive tract for certain medical procedures. The active ingredient was studied for its physical anti-foaming properties in multiple clinical settings, including randomized trials and systematic reviews.


Evidence for Relief of General Gas-Related Symptoms

This section summarizes findings from clinical trials that have examined research focused on common gas-related discomforts. Short-term Randomized Controlled Trials (RCTs) and systematic reviews were applied in studies examining patient-reported experiences of physical discomfort. Research examined outcomes related to physical discomfort, where participants recorded measurements of their abdominal distension and fullness over defined time intervals.

Studies report how symptoms evolved in the observed populations, and research describes the measurements taken when comparing the active ingredient to a placebo. Findings describe patterns observed in the studies related to changes in certain gas symptom measurements. However, evidence quality varies across studies, and some trials reported mixed findings. Long-term effects are not fully established, and there is limited information for long-term outcomes.


Evidence for Pre-procedural Defoaming in Diagnostic Studies

This part will outline the structure of evidence from meta-analyses and trials that have explored the ingredient’s potential use prior to diagnostic procedures like endoscopy or ultrasound. The active ingredient was evaluated in numerous clinical trials for its ability to clear small foam bubbles. Studies monitored the physical anti-foaming action by exploring immediate, physical outcomes such as the endoscopist's visual quality scores.

Research describes a consistent pattern where studies reported measurements indicating higher visual clarity scores and changes in bubble presence in patients who received the active ingredient. Meta-analyses described a consistent pattern where measured mucosal visibility scores were higher in the active treatment groups across pooled trials. However, data for certain groups remain insufficient regarding whether this clearer view reliably leads to significant differences in diagnostic outcomes.

Frequently Asked Questions (FAQ)

Common questions about Simcone (FAQ)


Q: Is Simcone the same type of medicine as [similar drug name]?

A: Simcone contains the active ingredient Simethicone, which official sources classify as an antiflatulent agent and a surface-active agent. This classification emphasizes that it is a non-systemic drug, meaning it only works physically within the digestive tract and is not absorbed into the body, which describes its mechanism of action as distinct from systemically absorbed medicines.

Q: Does Simcone cause weight gain or weight loss?

A: No. The official safety information and regulatory documents for Simcone do not list weight gain or weight loss among the documented side effects. This finding is consistent with the drug's action as a non-systemic agent that does not enter the bloodstream or interact with the body's metabolism.

Q: How long does it typically take to start noticing an effect from Simcone?

A: Because Simcone works directly on the trapped gas bubbles rather than having to be absorbed into the bloodstream, the onset of the physical effect is often described as quick. The purpose of the medicine is to provide relief on an as-needed basis by physically breaking down foam quickly within the gastrointestinal tract.

Q: What happens if I miss a dose of Simcone?

A: Since Simcone is typically used as-needed (PRN) for immediate symptomatic relief, regulatory information states that a missed dose is generally not a major concern. For patients taking it on a scheduled basis, official instructions often recommend skipping the dose if it is nearly time for the next scheduled administration and continuing the regular schedule.

Q: Is it common to feel tired when taking Simcone?

A: Tiredness or fatigue is not listed in the official regulatory safety profile as a common or uncommon side effect of Simcone. This is consistent with the fact that Simcone is a non-systemic medicine that does not act on the central nervous system.

Q: Does alcohol interact negatively with Simcone?

A: Official regulatory documents and official product information provide no explicit documentation of exposure-altering interactions between Simethicone and alcohol. This lack of documented interaction is due to Simcone’s non-systemic nature, which means it is not absorbed into the body.

Q: Are there any common foods or drinks that interact with Simcone?

A: Official regulatory documents provide no explicit documentation of exposure-altering interactions between Simethicone and common foods or drinks. The drug works through a localized physical mechanism, which prevents systemic drug-food interactions.

Q: Can Simcone interact with herbal remedies or vitamins?

A: Official product information provides no explicit documentation of absorption or exposure-altering interactions between Simethicone and herbal remedies or vitamins. However, official regulatory guidance encourages the disclosure of all products used to a healthcare provider.

Q: What kinds of medicines should I definitely tell my doctor about if I'm taking Simcone?

A: Regulatory documents describe potential absorption interference with specific oral medications, noting interactions with thyroid hormones (like Levothyroxine) and having associations reported with Carbamazepine. Regulatory guidance specifies a separation of at least four hours when taking Simcone with Levothyroxine.

Q: Is Simcone a long-term medication, or is it only used for a short time?

A: Simcone is indicated primarily for the short-term, as-needed (PRN) relief of acute gas symptoms. Official research summaries state that the long-term effects are not fully established and there is limited information for long-term outcomes.

Q: Will Simcone change the results of my blood tests?

A: It is not anticipated that Simcone will change the results of standard blood tests. Regulatory classification defines it as a non-systemic drug, meaning the active ingredient is not absorbed into the bloodstream to affect chemical or metabolic markers.

Q: Is it true that Simcone can affect sleep?

A: Official regulatory documents and the safety profile for Simethicone do not list any effects on sleep, such as insomnia or sedation. This aligns with its classification as a non-systemic medicine that does not act on the central nervous system.

Q: Is Simcone considered addictive or habit-forming?

A: No. Simcone is not classified as a controlled substance by regulatory bodies. Because it is a non-systemic agent that does not affect the central nervous system or engage biological receptors, it is not considered addictive or habit-forming.

Q: How is Simcone removed from the body?

A: Simcone is not metabolized (broken down) by the body because it is not absorbed into the bloodstream. It is eliminated from the body unchanged, passing out of the gastrointestinal tract primarily through the feces.

Q: Why does Simcone sometimes need a special prescription or monitoring?

A: While basic formulations of Simcone are generally available Over-The-Counter (OTC), use in specific clinical procedures, such as diagnostic imaging preparation, is overseen by a healthcare provider. Similarly, specialized formulations for certain age groups may be subject to specific oversight.

Q: Do people need to take blood tests while on Simcone?

A: Routine blood tests or therapeutic drug monitoring are not required by regulatory guidelines for the use of Simcone. This is due to the fact that the active ingredient is not absorbed into the systemic circulation.

Q: Is Simcone known to affect blood pressure?

A: Official regulatory documents and safety profiles do not list any documented changes or effects on blood pressure. This is consistent with Simcone's non-systemic medicine classification, which means it does not circulate in the bloodstream to affect the cardiovascular system.

Q: What evidence exists about Simcone's long-term safety?

A: Official research summaries state that there is limited information available regarding long-term outcomes for Simcone, and that its long-term effects are not fully established. Evidence focuses primarily on short-term symptom relief and pre-procedural defoaming.

Q: Does Simcone affect your ability to drive or operate machinery?

A: Official documentation does not typically include warnings about operating machinery or driving. This is because the active ingredient is not absorbed into the bloodstream and has no documented adverse effects on the central nervous system or consciousness.

Q: How soon after stopping Simcone does it leave the system?

A: Since the medicine is not absorbed and is eliminated unchanged, its departure from the body depends on the speed of transit through the digestive tract. Elimination from the gastrointestinal system typically occurs within a few hours after the last dose.

Q: What kind of specialist usually prescribes Simcone?

A: Simcone is widely available in its basic formulations as an Over-The-Counter (OTC) medicine. Therefore, it does not typically require a prescription or specific recommendation from any specialist or doctor for use in treating common gas discomfort.

Q: Is Simcone a controlled substance?

A: No, Simcone (Simethicone) is not classified as a controlled substance by the Drug Enforcement Administration (DEA) or other major government drug agencies.

Q: Do people need to avoid sunlight when taking Simcone?

A: Official regulatory documents do not list any warnings, precautions, or adverse reactions related to photosensitivity or the need to avoid sunlight while taking Simcone.

Q: What is the maximum amount of time a person can safely be on Simcone?

A: Simcone is indicated for short-term, as-needed relief of gas symptoms. While official safety information does not state a definitive safety cutoff, regulatory guidance indicates use is limited to symptomatic periods, as long-term effects are not fully established.

How should Simcone be stored and disposed of?

Simethicone Storage and Disposal Requirements

Official labeling mandates that Simethicone must be stored at room temperature, typically defined as 15 C to 30 C (59 F to 86 F). The medication must be kept away from excess heat and moisture; therefore, storage in the bathroom is discouraged. To maintain stability, the product should be stored in its original container and kept tightly closed.

Protection and Disposal

For child safety, the product must be stored out of the sight and reach of children and safety caps must remain locked. Unused or expired Simethicone must be disposed of in accordance with local requirements established by health authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Simcone found in:

A-Z Index: